What Mass General Brigham, Inc reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1678378 · Filed Nov 3, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
VANGUARD INTL EQUITY INDEX FTT WRLD ST ETF | 1.9M | New | $300.5M | 65.8% |
RVMDRevolution Medicines, Inc. | 344.1K | ±0% | $70.6M | 15.5% |
| 234.1K |
| New |
| $35.3M |
| 7.7% |
LYNXLyntris Inc. | 1.9M | New | $23.6M | 5.2% |
TNGXTango Therapeutics, Inc. | 354.2K | ±0% | $8.8M | 1.9% |
MAZEMaze Therapeutics, Inc. | 249.6K | +4.0% | $6.8M | 1.5% |
KRMNKarman Holdings Inc. | 209.3K | −86.6% | $6.8M | 1.5% |
MDLNMedline Inc. | 68.4K | ±0% | $2.4M | 0.5% |
IOTSamsara Inc. | 39.8K | New | $1.5M | 0.3% |